Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM et al..
2017.
Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.. Mol Neurodegener. 12(1):76.
Avissar M, Powell F, Ilieva I, Respino M, Gunning FM, Liston C, Dubin MJ.
2017.
Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS.. Brain Stimul. 10(5):919-925.
M Ross E, Mason CE, Finnell RH.
2017.
Genomic approaches to the assessment of human spina bifida risk.. Birth Defects Res. 109(2):120-128.
Baird-Daniel E, Daniel AGS, Wenzel M, Li D, Liou J-Y, Laffont P, Zhao M, Yuste R, Ma H, Schwartz TH.
2017.
Glial Calcium Waves are Triggered by Seizure Activity and Not Essential for Initiating Ictal Onset or Neurovascular Coupling.. Cereb Cortex. 27(6):3318-3330.
Schweitzer AD, Parikh NS, Askin G, Nemade A, Lyo J, Karimi S, Knobel A, Navi BB, Young RJ, Gupta A.
2017.
Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.. Neuroradiology. 59(4):379-386.
Reznik ME, Merkler AE, Mahta A, Murthy SB, Claassen J, Kamel H.
2017.
Long-term risk of seizures in adult survivors of sepsis.. Neurology. 89(14):1476-1482.
Cole DC, Chung Y, Gagnidze K, Hajdarovic KH, Rayon-Estrada V, Harjanto D, Bigio B, Gal-Toth J, Milner TA, McEwen BS et al..
2017.
Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology.. Proc Natl Acad Sci U S A. 114(50):13272-13277.
Sadler R, Singh V, Benakis C, Garzetti D, Brea D, Stecher B, Anrather J, Liesz A.
2017.
Microbiota differences between commercial breeders impacts the post-stroke immune response.. Brain Behav Immun. 66:23-30.
Pineda A, Burré J.
2017.
Modulating membrane binding of α-synuclein as a therapeutic strategy.. Proc Natl Acad Sci U S A. 114(6):1223-1225.
Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, Compadre CM, Goellner JJ, O'Brien CA, Fahmi T et al..
2017.
Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease.. Hum Mol Genet. 26(4):686-701.
Kawamata H, Peixoto P, Konrad C, Palomo G, Bredvik K, Gerges M, Valsecchi F, Petrucelli L, Ravits JM, Starkov A et al..
2017.
Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo.. Mol Neurodegener. 12(1):37.
Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al..
2017.
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.. Nat Med. 23(11):1369-1376.